We are live on
!
Find out more
CG
Carlyle Group Portfolio holdings
AUM
$10.6B
1-Year Est. Return
11.25%
This Fund
S&P 500
This Quarter
Est. Return
+0.5%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$12.6B
AUM Growth
-$2.14B
(-14%)
Cap. Flow
-$2.16B
Cap. Flow
% of AUM
-17.07%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTM
ZoomInfo Technologies
GTM
|
+$1.65B |
| 2 |
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
|
+$509M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.09% |
| 2 | Technology | 29.42% |
| 3 | Materials | 29.37% |
| 4 | Consumer Staples | 0.82% |
| 5 | Energy | 0.25% |
Similar funds
SGA
PF
BMSSC
EAM
WAM
HTC
CA
OIA
Carlyle Group's Q3 2021 Portfolio in Review
As of Q3 2021, Carlyle Group held 10 positions worth $12.6B, down 14% from $14.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Carlyle Group withdrew a net $2.16B in Q3 2021, reducing 2 holdings. Its largest reduction was ZoomInfo Technologies, cutting an estimated $1.65B.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, down from 41% a quarter earlier, followed by Technology and Materials.
- Carlyle Group's biggest Q3 2021 reduction was ZoomInfo Technologies, cutting an estimated $1.65B.
- Carlyle Group's ten largest holdings make up 100% of its $12.6B portfolio in Q3 2021.
- Carlyle Group opened 0 new positions and closed 0 in Q3 2021.
- Carlyle Group's portfolio value fell 14% quarter-over-quarter to $12.6B.
Based on Carlyle Group's 13F filing for Q3 2021, filed 12 Nov 2021.